Medicine by Design (MBD)


1 December 2017 - 30 November 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Medicine by Design (MBD) published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Medicine by Design (MBD) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

2 0.06

Outputs by subject (FC)

Subject AC FC
Physical Sciences 1 0.04

Top articles by Altmetric score in current window

Modulating cell state to enhance suspension expansion of human pluripotent stem cells

Proceedings of the National Academy of Sciences of the United States of America


1 December 2017 - 30 November 2018

International vs. domestic collaboration by FC

  • 22.81% Domestic
  • 77.19% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by FC (2 total)

  • Medicine by Design (MBD), Canada
  • Domestic institution
  1. The University of British Columbia (UBC), Canada (0.08)
  2. Department of Molecular Genetics, U of T, Canada (0.05)

Top 10 international collaborators by FC (3 total)

  • Medicine by Design (MBD), Canada
  • Foreign institution
  1. Weizmann Institute of Science (WIS), Israel (0.24)
  2. Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland (0.12)
  3. Imperial College London (ICL), United Kingdom (UK) (0.08)

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Return to institution outputs